76 related articles for article (PubMed ID: 4760525)
1. The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications.
Drewinko B; Brown BW; Gottlieb JA
Cancer Res; 1973 Dec; 33(12):3091-5. PubMed ID: 4760525
[No Abstract] [Full Text] [Related]
2. Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II).
Drewinko B; Green C; Loo TL
Cancer Treat Rep; 1976 Nov; 60(11):1619-25. PubMed ID: 1021234
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
Ducore JM; Erickson LC; Zwelling LA; Laurent G; Kohn KW
Cancer Res; 1982 Mar; 42(3):897-902. PubMed ID: 7199380
[TBL] [Abstract][Full Text] [Related]
4. Effects of cis-diamminedichloroplatinum (NSC 119875) on murine and human hemopoietic precursor cells.
Ogawa M; Gale GR; Keirn SS
Cancer Res; 1975 Jun; 35(6):1398-401. PubMed ID: 1131815
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent survival and cell-cycle progression of cultured cells exposed to chemotherapeutic drugs.
Drewinko B; Barlogie B
Cancer Treat Rep; 1976 Dec; 60(12):1707-17. PubMed ID: 1026329
[No Abstract] [Full Text] [Related]
6. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
Ara G; Kusumoto T; Korbut TT; Cullere-Luengo F; Teicher BA
Cancer Res; 1994 Mar; 54(6):1497-502. PubMed ID: 8137254
[TBL] [Abstract][Full Text] [Related]
7. Effects of simulated microgravity on proliferation and chemosensitivity in malignant glioma cells.
Takeda M; Magaki T; Okazaki T; Kawahara Y; Manabe T; Yuge L; Kurisu K
Neurosci Lett; 2009 Sep; 463(1):54-9. PubMed ID: 19628020
[TBL] [Abstract][Full Text] [Related]
8. Cis-diamminedichloroplatinum(II) augments expression of tumor-associated antigens on human gastric cancer cell line KATO-3 and increases susceptibility and binding of tumor cells to various cytotoxic effector cells.
Hayashi H; Nio Y; Kawabata K; Araya S; Imamura M
J Surg Oncol; 1996 Jul; 62(3):162-70. PubMed ID: 8667622
[TBL] [Abstract][Full Text] [Related]
9. Action of Cis-dichlorodiammineplatinum(II) (NSC-119875) at ehe cellular level.
Drewinko B; Gottlieb JA
Cancer Chemother Rep; 1975; 59(3):665-73. PubMed ID: 1203891
[TBL] [Abstract][Full Text] [Related]
10. Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells.
Frankel A; Mills GB
Clin Cancer Res; 1996 Aug; 2(8):1307-13. PubMed ID: 9816301
[TBL] [Abstract][Full Text] [Related]
11. Effects of mifepristone on the proliferation, apoptosis and cis-diamminedichloroplatinum sensitivity of cultured chemoresistant human ovarian cancer cells.
Wang G; Shang HL; Xie Y; Xiao P; Li XJ; Lin TC; Li GY
Chin Med J (Engl); 2005 Feb; 118(4):333-6. PubMed ID: 15740674
[No Abstract] [Full Text] [Related]
12. Comparison of the sister chromatid exchange and cell survival assays as a measure of tumor cell sensitivity in vitro to cis-diamminedichloroplatinum (II).
Tofilon PJ; Williams ME; Barcellos MH; Deen DF
Cancer Res; 1983 Aug; 43(8):3511-3. PubMed ID: 6683123
[TBL] [Abstract][Full Text] [Related]
13. L-histidinol increases the vulnerability of cultured human leukemia and lymphoma cells to anticancer drugs.
Warrington RC; Cheng I; Zhang L; Fang WD
Anticancer Res; 1993; 13(6A):2107-12. PubMed ID: 8297120
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB
Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621
[TBL] [Abstract][Full Text] [Related]
15. Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications.
Chu W; Pak BJ; Bani MR; Kapoor M; Lu SJ; Tamir A; Kerbel RS; Ben-David Y
Oncogene; 2000 Jan; 19(3):395-402. PubMed ID: 10656687
[TBL] [Abstract][Full Text] [Related]
16. [Interactions between X-rays and antimitotic drugs: cellular effects (author's transl)].
Laval F; Carde P; Michel S
Bull Cancer; 1981; 68(2):116-20. PubMed ID: 7195291
[TBL] [Abstract][Full Text] [Related]
17. Cycle-dependent anticancer drug cytotoxicity in mammalian cells synchronized by centrifugal elutriation.
Meyn RE; Meistrich ML; White RA
J Natl Cancer Inst; 1980 May; 64(5):1215-9. PubMed ID: 6154171
[TBL] [Abstract][Full Text] [Related]
18. RNA expression induced by cisplatin in an organ of Corti-derived immortalized cell line.
Previati M; Lanzoni I; Corbacella E; Magosso S; Giuffrè S; Francioso F; Arcelli D; Volinia S; Barbieri A; Hatzopoulos S; Capitani S; Martini A
Hear Res; 2004 Oct; 196(1-2):8-18. PubMed ID: 15464296
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of intracellular chloride regulation induce cisplatin resistance in canine osteosarcoma cells.
Yarbrough JW; Merryman JI; Barnhill MA; Hahn KA
In Vivo; 1999; 13(5):375-83. PubMed ID: 10654189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
